Castleman\'s disease (CD) is an angiofollicular lymph node hyperplasia.[@bib1] CD was described in 1956 by Benjamin Castleman who identified patients with solitary hyperplastic mediastinal lymph nodes presenting hyalinized follicles and a marked interfollicular vascular proliferation.[@bib2] In this article, we are presenting a case of CD affecting the parotid gland.

A 46-year-old female who found a painless lump on her left face that had at the time been present for 3 weeks. Physical examination revealed a soft, well-defined, fixed mass measuring 3 × 3 cm^2^ at the left periauricular area. Head and neck computer tomography showed a homogeneous enhancement mass involving the superficial and deep lobes of the left parotid gland ([Figure 1](#fig1){ref-type="fig"}A). Enlarged lymph nodes were noted along the left internal jugular vein ([Figure 1](#fig1){ref-type="fig"}B). The blood test data were within the normal ranges. Under the suspicion of a pleomorphic adenoma, parotidectomy was performed on September 8, 2010. The tumor measured 5.0 × 4.0 × 1.2 cm^3^ in size. Microscopically, most germinal centers in the lymph nodes were hyperplastic and areas of vascular proliferation could be seen in the interfollicular regions ([Figure 1](#fig1){ref-type="fig"}C). Foci showing lamination of the mantle cell layers with an "onion-skin" appearance were present ([Figure 1](#fig1){ref-type="fig"}D). These findings were suggestive of CD. Additional HHV-8 immunochemical staining of the lymph nodes was negative. Left facial muscle weakness and paresthesia were noted postoperatively. Muscular strength recovered 6 months postoperatively. The patient was still alive 5 years later.Figure 1Computer tomography images and histological microphotographs of our case of Castleman\'s disease. (A) Axial view showing a well-defined homogenous mass involving the superficial and deep lobes of parotid gland. (B) Axial view showing enlarged lymph nodes along the left internal jugular vein. (C) Areas of vascular proliferation seen in the interfollicular regions (hematoxylin and eosin stain, 100×). (D) Lamination of mantle cell layers with an "onion-skin" appearance (hematoxylin and eosin stain, 200×).Figure 1

The pathogenesis of CD is still not clearly understood. An association with HHV-8 was previously reported.[@bib1] Historically, CD is classified into three types: the hyaline-vascular type, the plasma-cell variant, and a mixture of the two. The two distinctive clinical characteristics are the presence of unicentric lymph nodes and that of multicentric lymph nodes. Unicentric CD (UCD) usually occurs in females[@bib2] and has localized manifestations with only a subset of the patients presenting systemic symptoms. Multicentric CD is frequently accompanied by systemic B-cell-related symptoms due to cytokine activation, and presents with fever, weight loss, night sweats, weakness, fatigue, and fluid retention.[@bib3] UCD is usually of the hyaline-vascular type and has a relatively benign course. In contrast, the plasma-cell variant and the mixed type are usually found in multicentric CD, and tend to be clinically aggressive. According to the systematic review performed by Talat and Schulte,[@bib4] the 3-year disease-free survival rate for patients with unicentric hyaline-vascular disease was 92.5%, as compared with 45.7% for those with multicentric plasma cell disease.[@bib4] Multicentric CD can be treated by cytotoxic chemotherapy with or without steroid agents.[@bib5] Targeting viral replication (with therapeutics such as zidovudine or valganciclovir) was one of the treatment options for maintenance therapy.

In conclusion, CD is a rare disease affecting the head and neck region. The gold standard for treating UCD has been surgery with regular follow-up. The patient, presenting with hyaline-vascular type UCD at the parotid gland, was still alive 5 years after surgical treatment.
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